Autoinflammatory Disease
14
7
7
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (14)
Studies of the Natural History, Pathogenesis, and Outcome of Autoinflammatory Diseases Including Juvenile Dermatomyositis
Effect of a Weekly Yoga Program Integrated Into Standard Care on Disease Activity, Fatigue, Mood, and Treatment Adherence in Patients With Systemic Autoimmune and Inflammatory Diseases: A Prospective Observational Study
Autoimmune and Autoinflammatory Genetics Study
Transition to Adulthood Through Coaching and Empowerment in Rheumatology
Biocollection of Rare Pediatric-onset of Autoimmune and Autoinflammatory Diseases
Development and Characterization of Functional Assays for the Analysis of Inflammation Signaling Pathways
Clinical Assessment for Rheumatologic Disease - Research and Advancement in Safety and Efficacy
Unclassified GENotypes of Autoinflammatory Diseases and AA Amyloidosis
Clinical Autoinflammatory Disease Cohort
Biomarkers in Autoimmune Diseases, Vasculitis and Auto Inflammatory Diseases
Pericardial Fluid Analysis in Recurrent Pericarditis
Flemish Joint Effort for Biomarker PRofiling in Inflammatory Systemic Diseases
Are Mast Cells Involved in Autoinflammatory Diseases
The CARRA Registry